These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 22532363)

  • 21. Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer.
    Cicero AFG; Allkanjari O; Busetto GM; Cai T; Larganà G; Magri V; Perletti G; Robustelli Della Cuna FS; Russo GI; Stamatiou K; Trinchieri A; Vitalone A
    Arch Ital Urol Androl; 2019 Oct; 91(3):. PubMed ID: 31577095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemoprevention of bladder cancer.
    Kamat AM; Lamm DL
    Urol Clin North Am; 2002 Feb; 29(1):157-68. PubMed ID: 12109342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Secondary prevention in patients with superficial urothelial carcinoma].
    Schnöller TJ; Zengerling F; Hirning C; Jentzmik F
    Urologe A; 2015 Jul; 54(7):992-7. PubMed ID: 25894992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of 5alpha-reductase inhibitors on the natural history, detection and grading of prostate cancer: current state of knowledge.
    Andriole G; Bostwick D; Civantos F; Epstein J; Lucia MS; McConnell J; Roehrborn CG
    J Urol; 2005 Dec; 174(6):2098-104. PubMed ID: 16280736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What's wrong with chemoprevention of prostate cancer?
    Justman S
    Am J Bioeth; 2011 Dec; 11(12):21-5. PubMed ID: 22146025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5alpha-reductase inhibitors in benign prostatic hyperplasia and prostate cancer risk reduction.
    Rittmaster RS
    Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):389-402. PubMed ID: 18471794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The REDUCE trial: chemoprevention in prostate cancer using a dual 5alpha-reductase inhibitor, dutasteride.
    Musquera M; Fleshner NE; Finelli A; Zlotta AR
    Expert Rev Anticancer Ther; 2008 Jul; 8(7):1073-9. PubMed ID: 18588452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of dutasteride on prostate carcinoma primary cultures: a comparative study with finasteride and MK386.
    Festuccia C; Gravina GL; Muzi P; Pomante R; Angelucci A; Vicentini C; Bologna M
    J Urol; 2008 Jul; 180(1):367-72. PubMed ID: 18499161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemopreventive trials in urologic cancer.
    Ashughyan VR; Marihart S; Djavan B
    Rev Urol; 2006; 8(1):8-13. PubMed ID: 16985555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantifying the impact of prostate volumes, number of biopsy cores and 5alpha-reductase inhibitor therapy on the probability of prostate cancer detection using mathematical modeling.
    Serfling R; Shulman M; Thompson GL; Xiao Z; Benaim E; Roehrborn CG; Rittmaster R
    J Urol; 2007 Jun; 177(6):2352-6. PubMed ID: 17509357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of herbal and over-the-counter dietary supplements for the prevention of prostate cancer.
    Bemis DL; Capodice JL; Costello JE; Vorys GC; Katz AE; Buttyan R
    Curr Oncol Rep; 2006 May; 8(3):228-36. PubMed ID: 16618388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostate cancer prevention: risk reduction through life-style, diet, and chemoprevention.
    Greco KE; Kulawiak L
    Oncol Nurs Forum; 1994 Oct; 21(9):1504-11. PubMed ID: 7816677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 5alpha-Reductase inhibitor treatment of prostatic diseases: background and practical implications.
    Dörsam J; Altwein J
    Prostate Cancer Prostatic Dis; 2009; 12(2):130-6. PubMed ID: 19030020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preventing Lethal Prostate Cancer with Diet, Supplements, and Rx: Heart Healthy Continues to Be Prostate Healthy and "First Do No Harm" Part I.
    Moyad MA
    Curr Urol Rep; 2018 Oct; 19(12):104. PubMed ID: 30368693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on prostate cancer chemoprevention.
    Lowe JF; Frazee LA
    Pharmacotherapy; 2006 Mar; 26(3):353-9. PubMed ID: 16503715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5-α reductase inhibitors and prostate cancer prevention: where do we turn now?
    Hamilton RJ; Freedland SJ
    BMC Med; 2011 Sep; 9():105. PubMed ID: 21920036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostate cancer prevention: past, present, and future.
    Fleshner N; Zlotta AR
    Cancer; 2007 Nov; 110(9):1889-99. PubMed ID: 17893870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NIH State-of-the-Science Conference Statement on Multivitamin/Mineral Supplements and Chronic Disease Prevention.
    NIH Consens State Sci Statements; 2006 May 15-17; 23(2):1-30. PubMed ID: 17332802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemoprevention of prostate cancer.
    Stephenson AJ; Abouassaly R; Klein EA
    Urol Clin North Am; 2010 Feb; 37(1):11-21, Table of Contents. PubMed ID: 20152515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of Gender and Age on the Willingness to Reduce Nicotine Consumption-Results of a Survey in Urological Cancer Patients (KRAUT Study).
    Dombrowski M; May M; Spachmann PJ; Ganesh Kumar M; Fritsche HM; Brookman-May S; Maurer O; Burger M; Gilfrich C
    Clin Genitourin Cancer; 2018 Dec; 16(6):e1181-e1187. PubMed ID: 30224329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.